Epicentre® Biotechnologies, founded in 1987, uses
its expertise in enzyme manufacturing to produce innovative kits for
life science research. The kits and reagents manufactured by Epicentre
contribute to breakthrough studies in genomics and transcriptomics. Products
are available for DNA and RNA sequencing, gene expression analysis, DNA
and RNA purification, PCR and RT-PCR, cloning, in vitro transcription,
and microbial genomics.
Epicentre's products are used worldwide in academic,
commercial, and government laboratories in diverse applications, including
basic research, drug discovery, cancer research, infectious disease research,
microbiology, and personalized medicine.
On January 10, 2011, Epicentre was
acquired by Illumina, Inc. The company continues to operate as
a wholly owned subsidiary of Illumina from its headquarters in Madison,
Wisconsin. [map]
|
